-
EZ Cap™ Cy5 EGFP mRNA: Delivery Workflows
2026-09-15
Build a dual-readout mRNA delivery assay that separates cellular uptake from productive translation. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) supports macrophage-targeted nanoparticle validation, live imaging, flow cytometry, and quantitative formulation troubleshooting.
-
Merimepodib (VX-497): Assay Reliability Guide
2026-09-15
This scenario-based guide explains how Merimepodib (VX-497), SKU B1112, can support reproducible cell proliferation, viability, immunosuppression, and antiviral research. It connects IMPDH biology with practical controls for dosing, solvent compatibility, interpretation, and product selection.
-
P2RX1 and Mitochondrial Apoptosis in Ph+ ALL
2026-09-14
Li et al. identify P2RX1 as a regulator of tyrosine kinase inhibitor sensitivity in Philadelphia chromosome-positive acute lymphoblastic leukemia, linking calcium/CaMKII activity to mitochondrial dysfunction and suppression of PI3K/Akt signaling. The study provides a mechanistic framework for interpreting apoptosis assays in Ph+ ALL, while also highlighting the need to distinguish phosphatidylserine exposure from broader mitochondrial and viability measurements.
-
Plastid DNA Breaks in Arabidopsis: DEtail-seq Insights
2026-09-14
The reference study uses DNA end tailing and sequencing (DEtail-seq) to define how plastid DNA breaks vary across Arabidopsis development, repair backgrounds, and environmental conditions. Its findings connect tissue age, ribosomal DNA vulnerability, R-loops, reactive oxygen species, and repair capacity while showing why direct DNA-break mapping should be paired with, rather than replaced by, oxidative-stress measurements.
-
Dinaciclib (SCH727965): CDK Mechanism & Use
2026-09-13
Dinaciclib (SCH727965) is a potent multi-CDK inhibitor for cancer research focused on cell-cycle control, Rb phosphorylation inhibition, and apoptosis induction in cancer cells. Its strongest evidence supports biochemical CDK inhibition, molecular response assays, and ovarian-cancer xenograft research, while tissue-boundary applications remain a mechanistic hypothesis rather than a validated indication.
-
Biotin-HPDP: Reliable Thiol Labeling
2026-09-12
Learn how Biotin-HPDP (SKU A8008) can add reversible thiol-specific protein labeling to viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers solvent compatibility, protocol controls, streptavidin detection, interpretation, and practical vendor selection.
-
KU-55933: Strategic ATM Inhibition in Translation
2026-09-11
A thought-leadership guide to using KU-55933 as a selective ATM kinase inhibitor for DNA damage response research, mechanistic validation, cell cycle arrest induction, and translational cancer research. The article connects ATM signaling with mitochondrial stress while defining practical assay controls, product-handling considerations, and the limits of pharmacologic inference.
-
Belinostat (PXD101) Experimental Workflows
2026-09-11
Belinostat (PXD101) is a practical pan-HDAC tool for separating chromatin-mediated growth arrest from tumor-cell killing. This workflow connects dose response, histone acetylation, cell-cycle profiling, and spliceosome-focused assays to support more informative cancer research.
-
TaqI Restriction Endonuclease: Practical Guide
2026-09-10
TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA containing the 5′…T↓CGA…3′ recognition sequence. It is suitable for research workflows such as mapping, cloning, and direct gel analysis, but it should not be used as a universal DNA cutter or for diagnostic and medical purposes.
-
Modified Ethanol Injection for mRNA Lipoplexes
2026-09-10
Tang and colleagues adapted a modified ethanol injection method to prepare cationic mRNA lipoplexes without specialized microfluidic equipment. Across 18 lipid combinations, DC-1-16/DOPE/PEG-Chol produced strong expression in cultured cells and in mouse lungs and spleen, illustrating how formulation composition can determine the performance of mRNA delivery systems.
-
Biophysical Design Rules for Lipid Nanoparticles
2026-09-09
The reference study combines sedimentation velocity analytical ultracentrifugation, field-flow fractionation with multiangle light scattering, and synchrotron small-angle X-ray scattering to resolve LNP heterogeneity beyond conventional size measurements. Its findings connect lipid composition and mixing method with particle size, RNA loading, shape, and mRNA translation, providing a more rigorous basis for interpreting delivery assays.
-
RNAi Screen Maps SARS-CoV-2 Release Factors
2026-09-09
Kerr et al. used an arrayed, druggable-genome RNA interference screen with time-resolved viral RNA measurements to identify host factors acting across the SARS-CoV-2 replication and release cycle. The study highlights Rab11a-dependent vesicular transport and shows that pharmacological CDK9 inhibition can suppress viral release, providing a mechanistic basis for host-targeted antiviral investigation.
-
Geneticin: Cell Selection and Assay Workflows
2026-09-08
Geneticin supports reproducible stable-cell selection while also enabling carefully controlled antiviral and mechanistic assays. This workflow-focused guide connects G418 selection to CLK2–BRCA1 platinum-resistance models without confusing selection pressure with biological treatment effects.
-
Arsenic Neurotoxicity, MMP-2/9, and BBB Injury
2026-09-08
A 2024 mouse study links chronic sodium arsenite exposure with cognitive impairment, blood–brain barrier disruption, and hippocampal neuronal apoptosis through an MMP-2/MMP-9-associated pathway. Its doxycycline intervention provides pharmacological evidence that preserving tight-junction integrity may reduce arsenic-related neurological injury, while also highlighting the limits of broad MMP inhibition as a mechanistic test.
-
ABT-263 Workflow for Apoptosis and Metabolism
2026-09-07
ABT-263 (Navitoclax) combines high-affinity Bcl-2 family inhibition with a practical platform for linking mitochondrial metabolism to apoptosis. This workflow shows how to pair apoptosis assays, optical redox imaging, and cell-state measurements so metabolic shifts are not mistaken for cell death.